UCB5.2%21NOV2029UCB5.2%21NOV2029UCB5.2%21NOV2029

UCB5.2%21NOV2029

No trades
See on Supercharts

Key terms


Outstanding amount
‪300.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
1,000.00EUR
Coupon
5.20% (Fixed)
Coupon frequency
Annual
Yield to maturity
3.66%
Maturity date
Nov 21, 2029
Term to maturity
5 years

About UCB5.2%21NOV2029


Issuer
Sector
Health Technology
Home page
Issue date
Nov 21, 2023
ISIN
BE0002976570
FIGI
BBG01K26B3W4
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.